About iSafety
iSafety is a Healthcare company based in Princeton (United States) founded in 2008, and was acquired by ProPharma Group in August 2021. Regulatory compliance, quality processes, and safety services are provided. The company has 113 employees. Its Indian entity Propharma Group India Private Limited reported revenue of ₹3.72 Cr. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.
Company details
iSafety was established in 2008 in Princeton, United States, as a provider in the compliance and safety sector. Regulatory compliance, quality process management, and safety solutions are delivered via its online platform at isafetysystems.com. Operations center on supporting businesses with tools and services for standards adherence, risk mitigation, and operational efficiency across various industries in the U.S. market.
- Headquarters Princeton, United States
- Employees 113
- Stage Acquired
- SectorsHealthcare
- Website isafetysystems.com
- Social LinkedIn X Instagram
- Acquired by ProPharma Group (Aug 2021)
- Legal Name Propharma Group India Private Limited
- Date of Incorporation 05 Dec, 2008
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹3.72 Cr
FY 2025 · -76% YoY
- Indian entity net loss-₹12.74 Cr
FY 2025 · -342% margin
- Indian entity EBITDA-₹12.41 Cr
FY 2025 · -333% margin
- Investors
- Employee Count113
- Acquired byProPharma Group
(Aug 2021)
Associated legal entities of iSafety
iSafety operates through Propharma Group India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Propharma Group India Private Limited CIN U72200TG2008PTC062114 | Active | 05 Dec 2008 | Hyderabad, Telangana | ₹3.7 Cr | 113 | 3 | View details |
Investors in iSafety
iSafety has secured backing from 1 investor. Prominent investors backing the company include ProPharma Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | 2001 | propharmagroup.com | Saint Paul, United States |
Investor details for iSafety
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Propharma Group India Private Limited (iSafety)
Propharma Group India Private Limited is the primary company behind iSafety. The board of Propharma Group India Private Limited currently have 3 directors; the longest-serving is Jason Jon Degoes, appointed in 2021. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jason Jon Degoes DIN 09186100 | Director | 07 Aug 2021 | 5 yrs 2 mo | Propharma Group India Private Limited |
| Srinivasa Pavan Kumar Hemadri DIN 10057890 | Director | 15 May 2023 | 3 yrs 5 mo | Propharma Group India Private Limited |
| Carl Barker DIN 10855718 | Director | 29 Nov 2024 | 1 yr 10 mo | Propharma Group India Private Limited |
Financials of iSafety
Figures of Propharma Group India Private Limited, the primary company behind iSafety, for FY 2025. Revenue was ₹3.72 Cr (-76% year on year). Net loss was -₹12.74 Cr (-342% margin). EBITDA was -₹12.41 Cr (-333% margin). Revenue has grown at a compounded annual rate of -37% over three years and -14% over five years.
- ₹3.72 CrRevenue · FY 2025 · -76% YoY
- -₹12.74 CrNet loss · -342% margin
- -₹12.41 CrEBITDA · -333% margin
- ₹1 LakhPaid-up capital
- 113Employees (provident fund records)
- -37%Revenue CAGR, 3 years
- -14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Propharma Group India Private Limited are on its company page.
Detailed financial statements for iSafety
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of iSafety
2 dated milestones of iSafety across 13 years, from founding to its latest funding, stage changes and deals.
- Founded iSafety is founded.
- Exit Acquired by ProPharma Group.
Competitors of iSafety
iSafety has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clearviewhcp.com | 2008 | Newton, United States | 381 | Strategic consulting services are provided to life sciences companies. |
Detailed competitors of iSafety
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as iSafety (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Isafety
Complete news archive for iSafety
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iSafety
iSafety was founded in 2008.
iSafety is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
iSafety has 113 employees.
The primary company behind iSafety, Propharma Group India Private Limited, reported revenue of ₹3.72 Cr for FY 2025, down 76% year on year.
iSafety was established in 2008 in Princeton, United States, as a provider in the compliance and safety sector. Regulatory compliance, quality process management, and safety solutions are delivered via its online platform at isafetysystems.com. Operations center on supporting businesses with tools and services for standards adherence, risk mitigation, and operational efficiency across various industries in the U.S. market.
iSafety's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.
iSafety has 1 investor. Key investors include ProPharma Group.
iSafety operates through Propharma Group India Private Limited.
Yes. iSafety was acquired by ProPharma Group in August 2021.
The legal entities of iSafety currently have 3 directors, including Jason Jon Degoes, Srinivasa Pavan Kumar Hemadri, Carl Barker.